Active Surveillance for Favorable Risk mRCC

Active Surveillance for Favorable Risk mRCC

kidneycancer

4 months
30 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael R. Harrison, MD Associate Professor of Medicine
Duke Cancer Institute discusses Active Surveillance for Favorable Risk mRCC at the 18th International Kidney Cancer Symposium 2019, Miami, FL.



Up Next Autoplay